88 related articles for article (PubMed ID: 26998671)
1. Tracking of STAT3 signaling for anticancer drug-discovery based on localized surface plasmon resonance.
Song S; Nguyen AH; Lee JU; Cha M; Sim SJ
Analyst; 2016 Apr; 141(8):2493-501. PubMed ID: 26998671
[TBL] [Abstract][Full Text] [Related]
2. Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer.
Huang M; Chen Z; Zhang L; Huang Z; Chen Y; Xu J; Zhang J; Shu X
Bioorg Med Chem Lett; 2016 Nov; 26(21):5172-5176. PubMed ID: 27727126
[TBL] [Abstract][Full Text] [Related]
3. Electrochemical detection of the Fc-STAT3 phosphorylation and STAT3-Fc-STAT3 dimerization and inhibition.
Martic S; Rains MK; Haftchenary S; Shahani VM; Kraskouskaya D; Ball DP; Gunning PT; Kraatz HB
Mol Biosyst; 2014 Mar; 10(3):576-80. PubMed ID: 24402062
[TBL] [Abstract][Full Text] [Related]
4. Antagonizing STAT3 dimerization with a rhodium(III) complex.
Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH
Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897
[TBL] [Abstract][Full Text] [Related]
5. Biosensor-Based Active Ingredients Recognition System for Screening STAT3 Ligands from Medical Herbs.
Chen L; Lv D; Chen X; Liu M; Wang D; Liu Y; Hong Z; Zhu Z; Hu X; Cao Y; Yang J; Chai Y
Anal Chem; 2018 Aug; 90(15):8936-8945. PubMed ID: 29953204
[TBL] [Abstract][Full Text] [Related]
6. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
7. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
Zhang M; Zhu W; Li Y
Eur J Med Chem; 2013 Apr; 62():301-10. PubMed ID: 23376248
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival.
Chen CL; Cen L; Kohout J; Hutzen B; Chan C; Hsieh FC; Loy A; Huang V; Cheng G; Lin J
Mol Cancer; 2008 Oct; 7():78. PubMed ID: 18939995
[TBL] [Abstract][Full Text] [Related]
10. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the inhibition of the STAT3 signaling pathway by EGCG.
Wang Y; Ren X; Deng C; Yang L; Yan E; Guo T; Li Y; Xu MX
Oncol Rep; 2013 Dec; 30(6):2691-6. PubMed ID: 24065300
[TBL] [Abstract][Full Text] [Related]
12. Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.
Sgrignani J; Garofalo M; Matkovic M; Merulla J; Catapano CV; Cavalli A
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843450
[TBL] [Abstract][Full Text] [Related]
13. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy.
Masciocchi D; Gelain A; Villa S; Meneghetti F; Barlocco D
Future Med Chem; 2011 Apr; 3(5):567-97. PubMed ID: 21526897
[TBL] [Abstract][Full Text] [Related]
14. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
[TBL] [Abstract][Full Text] [Related]
15. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
Furtek SL; Backos DS; Matheson CJ; Reigan P
ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
[TBL] [Abstract][Full Text] [Related]
16. Intermolecular disulfide bond influences unphosphorylated STAT3 dimerization and function.
Butturini E; Gotte G; Dell'Orco D; Chiavegato G; Marino V; Canetti D; Cozzolino F; Monti M; Pucci P; Mariotto S
Biochem J; 2016 Oct; 473(19):3205-19. PubMed ID: 27486258
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
18. The salicylanilide derivatives inhibit signal transducer and activator of transcription 3 pathways in A549 lung cancer cells.
Hu M; Ye W; Li J; Zhou P; Chu Z; Huang W
Anticancer Drugs; 2016 Jan; 27(1):41-7. PubMed ID: 26469835
[TBL] [Abstract][Full Text] [Related]
19. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Beebe JD; Liu JY; Zhang JT
Pharmacol Ther; 2018 Nov; 191():74-91. PubMed ID: 29933035
[TBL] [Abstract][Full Text] [Related]
20. Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
Huang Q; Zhong Y; Dong H; Zheng Q; Shi S; Zhu K; Qu X; Hu W; Zhang X; Wang Y
Eur J Med Chem; 2020 Feb; 187():111922. PubMed ID: 31810784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
